Skip to Content

ME-344 Approval Status

ME-344 is a novel mitochondrial inhibitor in development for the treatment of ovarian cancer and small cell lung cancer.

Development Status and FDA Approval Process for ME-344

Mar  8, 2012Marshall Edwards Submits Investigational New Drug Application for Oncology Drug Candidate ME-344

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.